Anderson Matthew W, Gorski Jack
Blood Research Institute, Blood Center of Southeastern Wisconsin, Milwaukee, WI 53201, USA.
J Immunol. 2003 Dec 1;171(11):5683-7. doi: 10.4049/jimmunol.171.11.5683.
Peptides presented via the class II MHC (MHCII) pathway are selected based on affinity for MHCII and stability in the presence of HLA-DM. Currently, epitope selection is thought to be controlled by the ability of peptide to sequester "anchor" residues into pockets in the MHCII. Residues exhibiting higher levels of solvent accessibility have been shown to contact TCR, but their roles in affinity and complex stability have not been directly studied. Using the HLA-DR1-binding influenza peptide, hemagglutinin (306-318), as a model, we show that side chain substitutions at these positions influence affinity and HLA-DM stability. Multiple substitutions reduce affinity to a greater extent than the loss of the major P1 anchor residue. We propose that these effects may be mediated through the H-bond network. These results demonstrate the importance of solvent-exposed residues in epitope selection and blur the distinctions between anchor and TCR contact residues.
通过II类主要组织相容性复合体(MHCII)途径呈递的肽是根据其对MHCII的亲和力以及在HLA-DM存在下的稳定性来选择的。目前,表位选择被认为受肽将“锚定”残基隔离到MHCII口袋中的能力控制。已显示具有较高溶剂可及性水平的残基会与T细胞受体(TCR)接触,但其在亲和力和复合物稳定性中的作用尚未得到直接研究。以与HLA-DR1结合的流感肽血凝素(306 - 318)为模型,我们表明这些位置的侧链取代会影响亲和力和HLA-DM稳定性。多个取代比主要P1锚定残基的缺失更大程度地降低亲和力。我们提出这些效应可能通过氢键网络介导。这些结果证明了溶剂暴露残基在表位选择中的重要性,并模糊了锚定残基和TCR接触残基之间的区别。